1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 454 F.Supp.3d
  5. 454 F.Supp.3d 407 (2020)
 

IN RE KERYX BIOPHARMACEUTICALS, INC.

Civil Action No. 18-1589-CFC.

454 F.Supp.3d 407 (2020)

IN RE KERYX BIOPHARMACEUTICALS, INC.

United States District Court, D. Delaware.

Signed April 15, 2020.

Attorney(s) appearing for the Case

Ryan M. Ernst , O'KELLY ERNST & JOYCE, LLC, Wilmington, Delaware; Alexandra B. Raymond , BRAGAR EAGEL & SQUIRE, P.C., New York, New York; Richard A. Acocelli , Michael A. Rogovin , Kelly K. Moran , WEISSLAW LLP, New York, New York, Counsel for Plaintiffs.

David E. Ross , ROSS, ARONSTAM & MORITZ LLP, Wilmington, Delaware; Peter L. Welsh , Christian Reigstad , ROPES & GRAY LLP, New York, New York, Counsel for Defendants.

MEMORANDUM OPINION

Lead Plaintiffs Abraham Kiswani and John Andreula filed this putative class action on behalf of themselves and all other public stockholders of Keryx Biopharmaceuticals, Inc. against Keryx Biopharmaceuticals, Inc. (Keryx) and the members of Keryx...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases